Virtus ETF Advisers »

Halozyme Therapeutics Inc Note 1.000 8/1 shares owned by Virtus ETF Advisers

Quarter-by-quarter ownership of Halozyme Therapeutics Inc Note 1.000 8/1 shares owned by Virtus ETF Advisers from 13F filings

Historical chart of Virtus ETF Advisers investment in Halozyme Therapeutics Inc Note 1.000 8/1

Tip: Access up to 7 years of quarterly data

All positions including Halozyme Therapeutics Inc Note 1.000 8/1 held by Virtus ETF Advisers consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Halozyme Therapeutics Inc Note 1.000 8/1 by Virtus ETF Advisers

Quarter filed Position value Share count Share price at filing
2025-09-30 $91k 65k 1.41
2025-06-30 $74k 65k 1.14
2025-03-31 $83k 65k 1.28

More positions owned by Virtus ETF Advisers

Ssr Mining (SSRM)
Icici Bank Adr (IBN)
Weibo Corp Sponsored Adr (WB)
Hdfc Bank Sponsored Ads (HDB)
Centerra Gold (CGAU)
Primoris Services (PRIM)
Ishares Tr Msci India Etf (INDA)
Grupo Cibest Sa Spon Ads (CIB)
Norwegian Cruise Line Hldg L SHS (NCLH)
Phibro Animal Health Corp Cl A Com (PAHC)
CommVault Systems (CVLT)
Globe Life (GL)
Nmi Hldgs Inc cl a (NMIH)
Ambarella SHS (AMBA)
Penguin Solutions (PENG)

View all positions for Virtus ETF Advisers

Top funds holding Halozyme Therapeutics Inc Note 1.000 8/1

Millennium Management
LMR Partners
Calamos Advisors
Camden Asset Management
Balyasny Asset Management
DLD Asset Management
Point72 Asset Management
Davidson Kempner Capital Management
Jpmorgan Chase & Co
Jain Global
Nuveen
Lazard Asset Management
State Street Corporation
Absolute Investment Advisers
Citadel Advisors

View all funds holding Halozyme Therapeutics Inc Note 1.000 8/1